Abstract session: Cirrhosis - Experimental aspects

 Cirrhosis and complications

Channel 4
English
Abstract session
27 August 2020 15:30 - 17:00


Presentations

Title Time

Add to Calendar

AS031 Toll-like receptor 4 inhibition acts synergistically with G-CSF to prevent organ injury and induce liver regeneration in acute-on-chronic liver failure
27 August 2020 15:30 - 15:45
AS032 A human liver cell-based system modeling a clinical prognostic liver signature combined with single cell RNA-Seq for discovery of novel liver disease therapeutics
27 August 2020 15:45 - 16:00
AS033 Neprilysin-neuropeptide Y axis as a target for treatment of liver fibrosis and portal hypertension
27 August 2020 16:00 - 16:15
AS034 Endothelial portal venous damage is associated with alterations in local TM and EPCR expression in patients with cirrhosis and portal hypertension
27 August 2020 16:15 - 16:30
AS035 The Albumin-functionality-test (AFT) as a new valuable tool to assess human albumin function and predict ACLF in patients with decompensated cirrhosis
27 August 2020 16:30 - 16:45
AS036 AXL-expressing homeostatic liver macrophages are reduced in patients with progression of cirrhosis
27 August 2020 16:45 - 17:00